J. Mori

发表

Administration of recombinant human growth hormone normalizes GH-IGF1 axis and improves malnutrition-related disorders in patients with anorexia nervosa.

K. Ichikawa, T. Kakizawa, K. Hashizume, 2007, Endocrine journal.

3,5,3'-Triiodo-l-Thyronine Potentiates All-Trans-Retinoic Acid-Induced Apoptosis during Differentiation of the Promyeloleukemic Cell HL-60.

K. Ichikawa, K. Hashizume, Satoru Suzuki, 1997, Endocrinology.

Multiple endocrine neoplasia type 1 concomitant with Prader-Willi syndrome: case report and genetic diagnosis.

Y. Fukushima, K. Hashizume, T. Aizawa, 1999, The American journal of the medical sciences.

Long-term follow-up of patients with multiple endocrine neoplasia type 1.

Y. Fukushima, K. Hashizume, A. Sakurai, 2007, Endocrine journal.

1,25-Dihydroxyvitamin D3 suppresses the expression of the VCAM-1 receptor, VLA-4 in human leukemic HL-60 cells.

K. Ichikawa, T. Kakizawa, K. Hashizume, 1999, Biochemical and biophysical research communications.

Chromogranin A expression in hepatocellular carcinoma in a patient with germline MEN1 gene mutation.

M. Katakura, K. Hashizume, A. Sakurai, 2000, Internal medicine.

Mechanism of liver-selective thyromimetic activity of SK&F L-94901: evidence for the presence of a cell-type-specific nuclear iodothyronine transport process.

K. Ichikawa, T. Kakizawa, K. Hashizume, 2000, The Journal of endocrinology.

Thyroid hormone regulation of apoptosis induced by retinoic acid in promyeloleukemic HL-60 cells: studies with retinoic acid receptor-specific and retinoid x receptor-specific ligands.

K. Ichikawa, T. Kakizawa, K. Hashizume, 2000, Thyroid : official journal of the American Thyroid Association.

Elevation of serum creatine kinase during treatment with antithyroid drugs in patients with hyperthyroidism due to Graves disease. A novel side effect of antithyroid drugs.

K. Ichikawa, K. Hashizume, T. Aizawa, 1997, Archives of internal medicine.

Atypical Wegener's granulomatosis with positive cytoplasmic antineutrophil cytoplasmic antibodies, ophthalmologic manifestations, and slowly progressive renal failure without respiratory tract involvement.

K. Ichikawa, T. Kakizawa, K. Hashizume, 1999, Internal medicine.

Functional Interaction between Oct-1 and Retinoid X Receptor*

K. Ichikawa, T. Kakizawa, K. Hashizume, 1999, The Journal of Biological Chemistry.

Silencing Mediator for Retinoid and Thyroid Hormone Receptors Interacts with Octamer Transcription Factor-1 and Acts as a Transcriptional Repressor*

K. Ichikawa, T. Kakizawa, K. Hashizume, 2001, The Journal of Biological Chemistry.

The role of hinge domain in heterodimerization and specific DNA recognition by nuclear receptors

K. Ichikawa, T. Kakizawa, T. Miyamoto, 2001, Molecular and Cellular Endocrinology.